Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Solifenacin Succinate in a Flexible Dose Regimen With Simplified Bladder Training Versus Solifenacin Succinate in a Flexible Dose Regimen Alone in a Prospective, Randomized, Parallel Group, Overactive Bladder Symptom Study

NCT00337558 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00337558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00337558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Solifenacin Succinate in a Flexible Dose Regimen With Simplified Bladder Training Versus Solifenacin Succinate in a Flexible Dose Regimen Alone in a Prospective, Randomized, Parallel Group, Overactive Bladder Symptom Study
Lead sponsor
Astellas Pharma Inc
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2006
Completion date
May 31, 2007
Enrollment
643 (actual)
Sites
64

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder, urge incontinence, urinary incontinence